News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
Mainz Biomed receives Swiss regulatory approval to market ColoAlert®, a non-invasive colorectal cancer screening test, following partnership with a local laboratory. The test aims to improve participation rates in CRC screening programs -
-
-
-